NOT-HL-18-590: Notice Announcing Frequently Asked Questions (FAQs) for PAR-18-577, New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 Clinical Trials Not Allowed)

Notice Announcing Frequently Asked Questions (FAQs) for PAR-18-577, New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 Clinical Trials Not Allowed)

Notice Number: NOT-HL-18-590

Key Dates
Release Date: February 01, 2018

Related Announcements
NOT-HL-17-490
NOT-HL-17-530
PAR-18-577
NOT-HL-18-587

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the NHLBI has posted a set of Frequently Asked Questions (FAQs) regarding applications for PAR-18-577, New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 Clinical Trial Not Allowed).
The FAQs are available on the NHLBI website and may be updated at any time without additional notice. Applicants are encouraged to view the FAQs prior to submitting their application and to check the site frequently for updates. Questions sent to NewEpiCohorts@nhlbi.nih.gov may be posted to the FAQs; however, identifying details about the applicant or proposed study will be removed prior to posting the question and response.

This FAQ page will also be the location where the Applicant Information Webinar slides and recording for PAR-18-577 will be posted; see NOT-HL-18-587 for more details about this Webinar.

Inquiries

Please direct all inquiries to:

Please direct all inquiries to:
NewEpiCohorts@nhlbi.nih.gov